Home
Live
News
Create
Screeners
Insights
Pfizer
5,118.
00
-37.00
(-0.72%)
Market Cap
₹23,413.69 Cr
PE Ratio
34.84
Industry
Healthcare
Buy
Sell
Company Performance:
1D
-0.72%
1M
+0.54%
6M
+25.67%
1Y
-16.75%
5Y
+1.64%
View Company Insights
Latest news about Pfizer
Pfizer Introduces Advanced 20-Valent Pneumococcal Vaccine for Adults in India
Aug 11, 2025
Pfizer Limited has introduced its next-generation 20-valent Pneumococcal Polysaccharide Conjugate Vaccine (PCV20) for adults in India. The vaccine offers protection against 20 serotypes of Streptococcus pneumoniae, surpassing previous conjugate vaccines in coverage. Administered as a single dose, it targets adults 18 years and older, particularly those over 50 and individuals with comorbidities. The vaccine aims to address the growing need for adult immunization in India and reduce the burden of pneumococcal disease.
Pfizer: Q4 Profit Soars 85%, Stock Surges 12%
May 20, 2025
Pfizer India Announces Robust Dividends and Q4 Financial Results
May 19, 2025
Pfizer Ltd Shares Surge 8% on Marketing Deal with Mylan, Despite Q3 Profit Dip
Feb 24, 2025
Pfizer Ltd Inks Marketing and Supply Deal with Mylan for Two Key Brands
Feb 21, 2025
Get More Market Insights with
Heatmap
FII/DII
Company Filings
MF Holdings
Bulk/Block Deals
Signals
MTF Insights
F&O Ban - MWPL
Top Deliveries
Market Valuation